The use of temporary mechanical circulatory support in cardiogenic shock has increased
dramatically despite a lack of randomized controlled trials or evidence guiding clinical …

There has been a significant increase in the use of short-term percutaneous ventricular
assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide …

The Impella device (Impella, Abiomed, Danvers, MA) is a percutaneous transvalvular
microaxial flow pump that is currently used for (1) cardiogenic shock,(2) left ventricular …

Short-term mechanical support by veno-arterial extracorporeal membrane oxygenation (VA
ECMO) is more and more applied in patients with severe cardiogenic shock. A major …

Although major advancements in the field of cardiology have allowed for an increasing
number of patients to undergo minimally invasive imaging and interventional procedures …

The Impella device is a catheter-based miniaturized ventricular assist device. Using a
retrograde femoral artery access, it is placed in the left ventricle across the aortic valve. The …

Background: Acute myocardial infarction remains a leading cause of chronic heart failure.
Excessive myocardial oxygen demand relative to supply is the fundamental mechanism of …

Introduction: The clinical impact of invasive hemodynamic support with Impella in patients
with cardiogenic shock (CS) remains to be defined. Methods: Only studies including patients …

While primary percutaneous coronary intervention (PCI) has significantly contributed to
improve the mortality in patients with ST segment elevation myocardial infarction even in …

Abstract Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to
reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) …